DRMA · Dermata Therapeutics, Inc. · Fails to Deliver
$1.15
+0.04 (+3.60%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because of historical and expected operating losses and net operating cash flow deficits, there is substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the financial statements, which is not alleviated by management's plans.”View the 10-Q filed Aug 11, 2026
Market Cap
$4.58M
Shares
4.02M
Volume · Oct 6
29.59K
Avg daily vol (3M)
700.21K
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-14 | 221 | $1.19 | $263 |
| 2026-09-10 | 968 | $1.21 | $1,171 |
| 2026-09-08 | 982 | $1.21 | $1,188 |
| 2026-09-02 | 1,685 | $1.30 | $2,191 |
| 2026-08-28 | 1,653 | $1.46 | $2,413 |
| 2026-08-27 | 622 | $1.61 | $1,001 |
| 2026-08-25 | 5,688 | $1.63 | $9,271 |
| 2026-08-24 | 3,018 | $1.42 | $4,286 |
| 2026-08-21 | 6,963 | $1.38 | $9,609 |
| 2026-08-18 | 37,712 | $1.46 | $55,060 |
| 2026-08-17 | 61,376 | $1.46 | $89,609 |
| 2026-08-14 | 160,223 | $1.57 | $251,550 |
| 2026-08-13 | 493,778 | $1.38 | $681,414 |
| 2026-08-12 | 487,798 | $1.08 | $526,822 |
| 2026-08-11 | 5,034 | $1.12 | $5,638 |
| 2026-08-10 | 2,700 | $1.10 | $2,970 |
| 2026-08-07 | 2,700 | $1.11 | $2,997 |
| 2026-08-05 | 129 | $1.10 | $142 |
| 2026-08-03 | 1,695 | $1.17 | $1,983 |
| 2026-07-29 | 756 | $1.24 | $937 |
| 2026-07-15 | 73 | $1.32 | $96 |
| 2026-07-10 | 27 | $1.34 | $36 |
Showing 1–22 of 22 settlements